UBS Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-350
Closed -$1K 10599
2022
Q2
$1K Sell
350
-1,868
-84% -$5.34K ﹤0.01% 9168
2022
Q1
$9K Sell
2,218
-2,209
-50% -$8.96K ﹤0.01% 7585
2021
Q4
$21K Buy
4,427
+3,727
+532% +$17.7K ﹤0.01% 6711
2021
Q3
$3K Sell
700
-1,727
-71% -$7.4K ﹤0.01% 7765
2021
Q2
$10K Sell
2,427
-1,399
-37% -$5.76K ﹤0.01% 7013
2021
Q1
$17K Sell
3,826
-6,874
-64% -$30.5K ﹤0.01% 6532
2020
Q4
$42K Sell
10,700
-2,382
-18% -$9.35K ﹤0.01% 5354
2020
Q3
$53K Sell
13,082
-6,763
-34% -$27.4K ﹤0.01% 4765
2020
Q2
$84K Sell
19,845
-6,561
-25% -$27.8K ﹤0.01% 4613
2020
Q1
$111K Sell
26,406
-4,566
-15% -$19.2K ﹤0.01% 4353
2019
Q4
$122K Buy
30,972
+18,690
+152% +$73.6K ﹤0.01% 4877
2019
Q3
$108K Buy
12,282
+9,987
+435% +$87.8K ﹤0.01% 4812
2019
Q2
$22K Sell
2,295
-1,074
-32% -$10.3K ﹤0.01% 5701
2019
Q1
$22K Sell
3,369
-13,871
-80% -$90.6K ﹤0.01% 5428
2018
Q4
$163K Sell
17,240
-16,461
-49% -$156K ﹤0.01% 4265
2018
Q3
$678K Buy
33,701
+26,563
+372% +$534K ﹤0.01% 3440
2018
Q2
$208K Sell
7,138
-90,484
-93% -$2.64M ﹤0.01% 4068
2018
Q1
$2.91M Buy
97,622
+82,109
+529% +$2.45M ﹤0.01% 2253
2017
Q4
$499K Sell
15,513
-3,650
-19% -$117K ﹤0.01% 3465
2017
Q3
$667K Sell
19,163
-9,552
-33% -$332K ﹤0.01% 3265
2017
Q2
$855K Buy
28,715
+22,684
+376% +$675K ﹤0.01% 3029
2017
Q1
$180K Sell
6,031
-2,061
-25% -$61.5K ﹤0.01% 3872
2016
Q4
$141K Sell
8,092
-2,395
-23% -$41.7K ﹤0.01% 4169
2016
Q3
$249K Sell
10,487
-1,138
-10% -$27K ﹤0.01% 3591
2016
Q2
$186K Sell
11,625
-839
-7% -$13.4K ﹤0.01% 3787
2016
Q1
$261K Sell
12,464
-25,423
-67% -$532K ﹤0.01% 3607
2015
Q4
$1.02M Buy
37,887
+28,637
+310% +$773K ﹤0.01% 2675
2015
Q3
$257K Sell
9,250
-3,262
-26% -$90.6K ﹤0.01% 3546
2015
Q2
$307K Buy
12,512
+9,221
+280% +$226K ﹤0.01% 3574
2015
Q1
$61K Sell
3,291
-1,020
-24% -$18.9K ﹤0.01% 4524
2014
Q4
$80K Buy
+4,311
New +$80K ﹤0.01% 4379